Cipla US arm recalls Vigabatrin for Oral Solution, USP 500mg over pouch leakage issues Ruchika Sharma11 Dec 2023 3:00 PM ISTCipla has not received any reports of adverse events related to this recall.
Cipla arm New York facility gets EIR from USFDA Ruchika Sharma12 Oct 2023 3:30 PM ISTMumbai: Cipla has announced that the New York manufacturing facility of InvaGen Pharmaceuticals Inc., a wholly-owned subsidiary of the Company,...
USFDA issues 5 observations to Cipla US arm Ruchika Sharma21 Sept 2023 12:30 PM ISTMumbai: Cipla has recently announced that the United States Food and Drug Administration (USFDA) has concluded the inspection with five...
Cipla arm gets zero Form 483 observations from USFDA for USA facility Ruchika Sharma3 May 2023 12:30 PM ISTMumbai: Cipla has recently announced that the US Food and Drug Administration has concluded inspection with zero Form 483 observations at the Fall...
